ADP
66
-2
PPL
82
-2
KR
65
-3
CVS
45
-2
ADSK
54
-2
EMN
53
-7
PAYX
53
2
PLD
35
-2
CVX
44
3
WBA
43
2
ALL
64
-2
SYK
48
2
NDAQ
70
4
SBUX
39
3
BMY
28
-5
CAH
61
3
K
66
-2
NWSA
78
3
ABBV
57
6
DUK
59
2
ADP
66
-2
PPL
82
-2
KR
65
-3
CVS
45
-2
ADSK
54
-2
EMN
53
-7
PAYX
53
2
PLD
35
-2
CVX
44
3
WBA
43
2
ALL
64
-2
SYK
48
2
NDAQ
70
4
SBUX
39
3
BMY
28
-5
CAH
61
3
K
66
-2
NWSA
78
3
ABBV
57
6
DUK
59
2
Financhill
Back

Gilead Sciences Vs. Rhythm Pharmaceuticals Industry Stock Comparison

Buy
65

GILD
Gilead Sciences

Last Price:
$103.13
Seasonality Move:
5.4%
Buy
63

RYTM
Rhythm Pharmaceuticals

Last Price:
$63.69
Seasonality Move:
15.42%
Buy
65
Gilead Sciences (GILD) is a Buy

Is Gilead Sciences a Buy, Sell or Hold?

  • The current Gilead Sciences [GILD] share price is $103.17. The Score for GILD is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
  • GILD is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
63
Rhythm Pharmaceuticals (RYTM) is a Buy

Is Rhythm Pharmaceuticals a Buy, Sell or Hold?

  • The current Rhythm Pharmaceuticals [RYTM] share price is $63.76. The Score for RYTM is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
  • RYTM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

GILD Stock Price Chart

What is Gilead Sciences's stock price today?

  • The Gilead Sciences share price today is $103.17
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GILD is experiencing buying pressure, which is a positive indicator for future bullish movement.

RYTM Stock Price Chart

What is Rhythm Pharmaceuticals's stock price today?

  • The Rhythm Pharmaceuticals share price today is $63.76
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing buying pressure, which is a positive indicator for future bullish movement.

GILD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.02 Sell
Relative Strength Index (14 RSI): 41.05 Sell
Chaikin Money Flow: 11499605 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (103.88 - 110.12) Sell
Bollinger Bands (100): (92.37 - 109.45) Buy

RYTM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.28 Buy
Relative Strength Index (14 RSI): 63.66 Buy
Chaikin Money Flow: 369446 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (52.02 - 61.16) Buy
Bollinger Bands (100): (53.03 - 59.91) Buy

GILD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 105.08 Sell
20-day SMA: 106.64 Sell
50-day SMA: 108.69 Sell
200-day SMA: 91.13 Buy
8-day EMA: 105.06 Sell
20-day EMA: 106.14 Sell
50-day EMA: 105.7 Sell
200-day EMA: 94.08 Buy

RYTM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 61.43 Buy
20-day SMA: 57.42 Buy
50-day SMA: 55.27 Buy
200-day SMA: 53.46 Buy
8-day EMA: 61.16 Buy
20-day EMA: 58.64 Buy
50-day EMA: 56.64 Buy
200-day EMA: 52.62 Buy

Gilead Sciences Earnings Growth & GILD Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.63 per share, a decrease next quarter of $0.11 per share, an increase this year of $3.55 per share, and an increase next year of $0.48 per share.

Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.26 per share, an increase next quarter of $0.07 per share, an increase this year of $1.54 per share, and an increase next year of $1.14 per share.

Gilead Sciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Rhythm Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):